2012
DOI: 10.1155/2012/140284
|View full text |Cite
|
Sign up to set email alerts
|

On the Discovery, Biological Effects, and Use of Cisplatin and Metallocenes in Anticancer Chemotherapy

Abstract: The purpose of this paper is to summarize mode of action of cisplatin on the tumor cells, a brief outlook on the metallocene compounds as antitumor drugs as well as the future tendencies for the use of the latter in anticancer chemotherapy. Molecular mechanisms of cisplatin interaction with DNA, DNA repair mechanisms, and cellular proteins are discussed. Molecular background of the sensitivity and resistance to cisplatin, as well as its influence on the efficacy of the antitumor immune response was eva… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
55
0
9

Year Published

2014
2014
2023
2023

Publication Types

Select...
8
1

Relationship

3
6

Authors

Journals

citations
Cited by 123 publications
(65 citation statements)
references
References 127 publications
(144 reference statements)
0
55
0
9
Order By: Relevance
“…Moreover, the high toxicity of cisplatin, due to its preferential binding to non-DNA targets, depends on the cellular redox state. Namely, it is known that only 5-10% intracellular concentration of cisplatin is found in DNA fraction, while 75-85% binds to nucleophilic sites of intracellular constituents, such as thiol-containing peptides, proteins, replication enzymes, and RNA [24]. It can be speculated that disturbances in redox status of tumor cells and increased GSTO1 deglutathionylase activity could affect this process through the changes in glutathionylation/deglutathionylation balance, in which case high thiol groups favor cisplatin binding to proteins.…”
Section: Discussionmentioning
confidence: 99%
“…Moreover, the high toxicity of cisplatin, due to its preferential binding to non-DNA targets, depends on the cellular redox state. Namely, it is known that only 5-10% intracellular concentration of cisplatin is found in DNA fraction, while 75-85% binds to nucleophilic sites of intracellular constituents, such as thiol-containing peptides, proteins, replication enzymes, and RNA [24]. It can be speculated that disturbances in redox status of tumor cells and increased GSTO1 deglutathionylase activity could affect this process through the changes in glutathionylation/deglutathionylation balance, in which case high thiol groups favor cisplatin binding to proteins.…”
Section: Discussionmentioning
confidence: 99%
“…The 1,2-intrastrand d(GpG) cross-link is the major adduct. Binding of cisplatin to DNA causes significant distortion of the helical structure and results in inhibition of DNA replication and transcription ( Figure 2) [6]. The Pt 2+ unit covalently binds to deoxyribonucleic acid (DNA), particularly to the N7 of either guanine (G) or adenine (A) in the nucleotide sequences GG and AG to form interstrand cross-links [7] The so-formed cisplatin-DNA unit activates a new cellular pathway which leads to transcription inhibition, cell-cycle arrest, DNA repair, and finally apoptosis [8].…”
Section: Introductionmentioning
confidence: 99%
“…The two major problems associated with the use of cisplatin derivatives are the severe toxic side effects (11)(12)(13)(14)(15) and the intrinsic or acquired resistance manifested in various types of cancers (16). Therefore, in recent decades, a large number of new metal-based complexes have been developed and tested (17)(18)(19).…”
Section: Introductionmentioning
confidence: 99%